Journal ArticleOPEN ACCESS

ARTEMIS: 192‐week efficacy and safety of once‐daily darunavir/ritonavir (DRV/r) vs lopinavir/r (LPV/r) in treatment‐naïve HIV‐1‐infected adults

  • Orkin C
  • DeJesus E
  • Khanlou H
  • et al.
Journal of the International AIDS Society (2010) 13(S4)
DOI: 10.1186/1758-2652-13-s4-p3
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK

Cite

CITATION STYLE

APA

Orkin, C., DeJesus, E., Khanlou, H., Stoehr, A., Supparatpinyo, K., Van de Casteele, T., … Spinosa‐Guzman, S. (2010). ARTEMIS: 192‐week efficacy and safety of once‐daily darunavir/ritonavir (DRV/r) vs lopinavir/r (LPV/r) in treatment‐naïve HIV‐1‐infected adults. Journal of the International AIDS Society, 13(S4). https://doi.org/10.1186/1758-2652-13-s4-p3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free